Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer

Transplantation

Volumn 65, Issue 9, 1998, Pages 1233-1240

  Bagley, Jessamyn ^a   Aboody Guterman, Karen ^a   Breakefield, Xandra ^a   Iacomini, John ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CELL SELECTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; BONE MARROW CELLS; CELL LINE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MICE; RETROVIRIDAE; TIME FACTORS; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY;

EID: 0032525059     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00015     Document Type: Article

References (52)

1. Link CJJ, Beecham EJ. Human gene therapy trials for cancer. J Biotech Healthcare 1994; 2: 183.
2. Miller AD. Genetic manipulation of hematopoietic stem cells. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Cambridge: Blackwell Scientific Publications, 1992; 72
3. Szilvassy SJ, Fraser CC, Eaves CJ, Lansdorp PM, Eaves AC, Humphries RK. Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA 1989; 86: 8798.
4. Bagnis C, Gravis G, Imbert AM, et al. Retroviral transfer of the LacZ gene into human CD34+ cell populations and into TF-1 cells: future prospects in gene therapy. Hum Gene Ther 1994; 5: 1325.
5. Schreiber JH, Schisa JA, Wilson JM. Recombinant retroviruses containing novel reporter genes. BioTechniques 1993; 14: 818.
6. Pawliuk R, Kay R, Lansdorp P, Humpries RK. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 1994; 84: 2868.
7. Planelles V, Haislip A, Withers-Ward ES, et al. A new reporter system for detection of retroviral infection. Gene Ther 1995; 2: 369.
8. Mavilio F, Ferrari G, Rossini S, et al. Peripheral blood lymphocytes as target cells of retroviral vector mediated gene transfer. Blood 1996; 87: 1754.
9. Phillips K, Gentry T, McCowage G, Gilboa E, Smith C. Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nat Medi 1997; 2: 1154.
10. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802.
11. Levy JP, Muldoon RR, Zolotukhin S, Link CJJ. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nat Biotechnol 1996; 14: 610.
12. Cheng L, Fu J, Tsukamoto A, Hawley RG. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat Biotechnol 1996; 14: 606.
13. Muldoon RR, Levy JP, Kain SR, Link CJJ. Tracking and quantitation of retroviral mediated transfer using a completely humanized, red-shifted green fluorescent protein gene. Bio-Techniques 1997; 22: 162.
14. Prasher DC. Using GFP to see the light. Trends Genet 1995; 11: 320.
15. Persons DA, Allay JA, Allay ER, et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997; 90: 1777.
16. Heim R, Cubitt AB, Tsien RY. Improved green fluorescence. Nature 1995; 373: 663.
17. Gerdes HH, Kaether C. GFP: applications in cell biology. FEBS Lett 1996; 389: 44.
18. Coffman B. Surface antigen expression and immunoglobulin rearrangement during mouse pre-B cell development. Immunol Rev 1982; 69: 5.
19. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 1990; 171: 1753.
20. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58.
21. Ilkuta K, Kina T, MacNeil I, et al. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 1990; 62: 863.
22. Ho M, Springer TA. Mac-1 antigen: quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J Immunol 1982; 128: 2281.
23. Springer TA, Galfre G, Secher DS, Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 1979; 9: 301.
24. Ikuta K, Weissman I. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 1992; 89: 1502.
25. Aboody-Guterman KS, Rainov NG, Pechan P, et al. Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo. NeuroReport 1997; 8: 3801.
26. Hawley RG, Sabourin LA, Hawley TS. An improved retroviral vector for gene transfer into undifferentiated cells. Nucleic Acids Res 1989; 17: 4001.
27. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosomal entry site allows efficient coexpression of two genes from a recombinant pro-virus in cultured cells and embryos. Mol Cell Biol 1991; 11: 5848.
28. Markovitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400.
29. Fraser CC, Sykes M, Stanton-Lee R, Sachs DH, LeGuern C. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol 1995; 154: 1587.
30. Sawada T, Wu Y, Sachs DH, Iacomini J. CD4+ T cells are able to reject class I disparate allografts. Transplantation 1997; 64: 335.
31. Hantzopoulos PA, Sullenger BA, Ungers G, Gilboa E. Improved gene expression upon transfer on the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc Natl Acad Sci USA 1989; 86: 3519.
32. Uchida N, Weissman IL. Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-thy-1.1 bone marrow. J Exp Med 1992; 175: 175.
33. Ikuta K, Uchida N, Friedman J, Weissman IL. Lymphocyte development from stem cells. Annu Rev Immunol 1992; 10: 759.
34. Aguila HL, Akashi K, Domen J, et al. From stem cells to lymphocytes: biology and transplantation. Immunol Rev 1997; 157: 13.
35. Ikawa M, Kominami K, Yoshimura Y, Tanaka K, Nishimune Y, Okabe M. A rapid and non-invasive selection of transgenic embryos before implantation using GFP. FEBS Lett 1995; 375: 125.
36. Weissman IL. Developmental switches in the immune system. Cell 1994; 76: 207.
37. Bodine DM, Karlsson S, Nienhuis AW. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci USA 1989; 86: 8897.
38. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol 1991; 19: 206.
39. Hanazono Y, Yu J, Dunbar CE, Emmons RVB. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum Gene Ther 1997; 8: 1313.
40. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102: 400.
41. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance to foreign cells. Nature 1953; 172: 603.
42. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231.
43. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307(5947): 168.
44. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197.
45. Stanton-Mayfield R, Hideki H, Sawada T, et al. The mechanism of specific prolongation of class I mismatched skin grafts induced by retroviral gene therapy. Eur J Immunol 1997; 27: 1177.
46. Schumacher IK, Newberg MH, Jackson JD, et al. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. Transplantation 1996; 62: 831.
47. Zambidis ET, Kurup A, Scott DW. Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunoglobulin epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med 1997; 3: 212.
48. Van Ewijk W, Ron Y, Monaco J, et al. Compartmentalization of MHC class II gene expression in transgenic mice. Cell 1988; 53: 357.
49. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273.
50. Schulz R, Mellor AL. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment. J Exp Med 1996; 184: 1573.
51. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541.
52. Kabat D. Targeting retroviral vectors to specific cells. Science 1995; 269: 417.